r RVNC Stock Quote - Revance Therapeutics, Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Revance Therapeutics, Inc.
(NASDAQ : RVNC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.44%165.230.4%$241.40m
VRXValeant Pharmaceuticals International, Inc.
0.07%22.2414.1%$211.47m
PRGOPerrigo Co. Plc
0.16%75.236.7%$103.69m
JAZZJazz Pharmaceuticals Plc
0.88%165.022.2%$91.57m
PTLAPortola Pharmaceuticals, Inc.
2.15%40.877.7%$78.12m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.71%161.107.6%$64.33m
SAGESAGE Therapeutics, Inc.
-1.80%155.339.6%$58.04m
MNKMallinckrodt Plc
0.37%16.5021.1%$57.03m
SUPNSupernus Pharmaceuticals, Inc.
2.88%57.256.3%$49.76m
PBHPrestige Brands Holdings, Inc.
2.21%34.653.8%$41.14m
UTHRUnited Therapeutics Corporation
-1.08%103.6014.4%$36.56m
HZNPHorizon Pharma plc
4.19%16.177.5%$33.22m
CTLTCatalent Inc
0.13%38.862.6%$31.43m
ICPTIntercept Pharmaceuticals, Inc.
1.88%71.0721.8%$30.30m
ENDPEndo International Plc
0.80%6.318.9%$29.81m

Company Profile

Revance Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.